Multivariate analysis for risk of death after transplantation
| Risk factor . | RR . | 95% CI . | P . |
|---|---|---|---|
| Donor type | |||
| Maternal donor | 1.00 | — | — |
| Paternal donor | 2.36 | 1.35-4.15 | .003 |
| Disease status at transplantation | |||
| Remission | 1.00 | — | — |
| Relapse | 1.69 | 1.05-2.71 | .03 |
| NK alloreactivity | |||
| KIR ligand mismatch | 1.00 | — | — |
| No KIR ligand mismatch (up to 6 months) | 1.16 | 0.61-2.22 | .65 |
| No KIR ligand mismatch (after 6 months) | 5.07 | 1.70-15.2 | .004 |
| Patient age per increasing year | 1.033 | 1.007-1.061 | .01 |
| Risk factor . | RR . | 95% CI . | P . |
|---|---|---|---|
| Donor type | |||
| Maternal donor | 1.00 | — | — |
| Paternal donor | 2.36 | 1.35-4.15 | .003 |
| Disease status at transplantation | |||
| Remission | 1.00 | — | — |
| Relapse | 1.69 | 1.05-2.71 | .03 |
| NK alloreactivity | |||
| KIR ligand mismatch | 1.00 | — | — |
| No KIR ligand mismatch (up to 6 months) | 1.16 | 0.61-2.22 | .65 |
| No KIR ligand mismatch (after 6 months) | 5.07 | 1.70-15.2 | .004 |
| Patient age per increasing year | 1.033 | 1.007-1.061 | .01 |
Pretransplant variables without statistically significant impact on survival: patient sex, disease, center, date of transplantation, donor age, CMV serologic status in the donor/recipient pair, and graft CD3 and CD34 count.
— indicates not applicable.